Matches in Nanopublications for { ?s ?p "[We then projected the effectiveness of tissue plasminogen activator (TPA) on disability as estimated with the aid of the odds ratio from the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial onto our unselected sample to evaluate clinical efficiency of treatment as a function of arrival time and of hypothetical effects of educational efforts to reduce it.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP26051.RAY6eTqyGkLkE1uShV6nGSmWu-5S5zrUav4BxtC_lPdHQ130_assertion description "[We then projected the effectiveness of tissue plasminogen activator (TPA) on disability as estimated with the aid of the odds ratio from the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial onto our unselected sample to evaluate clinical efficiency of treatment as a function of arrival time and of hypothetical effects of educational efforts to reduce it.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26051.RAY6eTqyGkLkE1uShV6nGSmWu-5S5zrUav4BxtC_lPdHQ130_provenance.
- NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_assertion description "[We then projected the effectiveness of tissue plasminogen activator (TPA) on disability as estimated with the aid of the odds ratio from the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial onto our unselected sample to evaluate clinical efficiency of treatment as a function of arrival time and of hypothetical effects of educational efforts to reduce it.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_provenance.
- assertion description "[We then projected the effectiveness of tissue plasminogen activator (TPA) on disability as estimated with the aid of the odds ratio from the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial onto our unselected sample to evaluate clinical efficiency of treatment as a function of arrival time and of hypothetical effects of educational efforts to reduce it.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We then projected the effectiveness of tissue plasminogen activator (TPA) on disability as estimated with the aid of the odds ratio from the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial onto our unselected sample to evaluate clinical efficiency of treatment as a function of arrival time and of hypothetical effects of educational efforts to reduce it.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.